U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Links from BioSample

SRX745915: GSM1533474: colistin 2mg 15min R2; Acinetobacter baumannii ATCC 19606 = CIP 70.34 = JCM 6841; RNA-Seq
3 ILLUMINA (Illumina MiSeq) runs: 4.5M spots, 226.1M bases, 145Mb downloads

Submitted by: NCBI (GEO)
Study: The transcriptomic response of Acinetobacter baumannii to colistin and doripenem alone and in combination in an in vitro pharmacokinetics/pharmacodynamics model
show Abstracthide Abstract
Objectives: Colistin remains a last-line treatment for multidrug-resistant Acinetobacter baumannii and combined use of colistin and carbapenems has shown synergistic effects against multidrug-resistant strains. In order to understand the bacterial responses to these antibiotics we analysed the transcriptome of A. baumannii following exposure to each. Overall design: Methods: RNA sequencing was employed to determine changes in the transcriptome following treatment with colistin and doripenem, both alone and in combination, using an in vitro pharmacokinetics/pharmacodynamics (PK/PD) model to mimic the pharmacokinetics of both antibiotics in patients.
Sample: colistin 2mg 15min R2
SAMN03145778 • SRS732601 • All experiments • All runs
Library:
Instrument: Illumina MiSeq
Strategy: RNA-Seq
Source: TRANSCRIPTOMIC
Selection: cDNA
Layout: SINGLE
Construction protocol: Approximately 75 mL of each culture was transferred to sterile Falcon tubes and cells harvested by centrifugation (4,000 × g for 10 min) at 4°C. The supernatant was removed, and cells were resuspended in 1 mL of RNAlater RNA Stabilization Reagent (Qiagen) and stored at 4°C for up to 4 days. Cell samples, previously resuspended in RNAlater,were centrifuged at 5,000 × g for 10 min, and the supernatant discarded. The pellet was then resuspended in 200 µL of 10 mg/mL lysozyme (Sigma) in TE buffer to which 1 µL Protector RNase Inhibitor (Roche) had been added. The solution was vortex-mixed for 10 sec and incubated at room temperature for 10 min, with further vortex mixing for 10 sec every 2 min. RNA was purified and concentrated using the RNeasy MinElute Cleanup Kit (Qiagen), according to the manufacturer's RNA cleanup protocol, including an on-column DNase treatment using the RNase-free DNase Set (Qiagen). An additional step was performed after the addition of 700 µL of Buffer RLT to the extracted RNA, as follows; samples were vortex-mixed vigorously and centrifuged at 5,000 × g for 5 min to pellet any precipitate. The supernatant was transferred to a fresh tube and RNA precipitated by the addition of three volumes of ethanol. For further elimination of contaminating DNA, the isolated RNA was treated again with the RNase-free DNase Set (Qiagen), according to the manufacturer's protocol. The construction of the cDNA library from purified RNA samples was performed using the Truseq RNA Preparation Kit (Illumina). Ribosomal RNA (rRNA) was removed from the samples using the Ribozero kit (Epicentre). Approximately 300 ng of rRNA-depleted RNA was used as input, following the manufacturer's protocol (low throughput).
Experiment attributes:
GEO Accession: GSM1533474
Links:
Runs: 3 runs, 4.5M spots, 226.1M bases, 145Mb
Run# of Spots# of BasesSizePublished
SRR1634119907,82945.5M27.8Mb2014-12-01
SRR16341201,823,20891.3M58.5Mb2014-12-01
SRR16341211,782,15189.3M58.6Mb2014-12-01

ID:
1079184

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...